Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01004562 · ClinicalTrials.gov registry record
Collecting Information From Patients Enrolled in the Breast Specialized Program of Research Excellence
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 1,025
- Enrollment target
NCT01004562: Completed study, sponsored by University of Alabama at Birmingham.
NCT01004562 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 1,025 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01004562 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 1,025 participants
- Enrollment target
Study Summary
RATIONALE: Collecting and storing information from patients with cancer to study in the future may help doctors learn more about cancer. PURPOSE: This study is collecting information from patients enrolled in the Breast Specialized Program of Research Excellence.
Interventions
- OTHER informational intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,025 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-08 |
What the finished NCT01004562 record still lists
NCT01004562 is an observational study that tracks outcomes without assigning an intervention. Its 1,025 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which informational intervention is the first listed.
NCT01004562 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01004562 about?
NCT01004562 is a clinical study titled "Collecting Information From Patients Enrolled in the Breast Specialized Program of Research Excellence". RATIONALE: Collecting and storing information from patients with cancer to study in the future may help doctors learn more about cancer. PURPOSE: This study is collecting information from patients enrolled in the Breast Specialized Program of Research Excellence.
What is the current status of trial NCT01004562?
This trial is currently completed. The enrollment target is 1,025 participants. The study started on 2007-08. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01004562?
The interventions under investigation include: informational intervention (OTHER).
Who is sponsoring clinical trial NCT01004562?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02200276 · 1,025 participants · NA
Influenza Immunization in Adults Over Age 75
- NCT02296450 · 1,025 participants
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
- NCT06888011 · 1,024 participants · NA
iAmHealthy Clinical Practice Guideline (CPG)
- NCT07216703 · 1,023 participants · Phase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia